MOLECULAR CHARACTERIZATION AND EPIDEMIOLOGY OF DENGUE VIRUS IN CENTRAL INDIA: INSIGHTS INTO SEROTYPE DISTRIBUTION AND EVOLUTIONARY TRENDS

Main Article Content

Rashmi Ranjan Rout
Dr. Debasish Samal
Dr. Monalisa Subudhi
Dr. V.K. Ramnani

Keywords

Dengue virus, Molecular characterization, Serotype distribution, Central India, Epidemiology, Evolutionary trends

Abstract

Dengue virus (DENV) is a significant public health concern, particularly in tropical and subtropical regions where it causes a wide range of clinical manifestations, from mild febrile illness to severe forms like dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). This study focuses on the molecular characterization of DENV strains circulating in Central India, an area prone to frequent dengue outbreaks. By analyzing genomic data from clinical samples, we aimed to elucidate the serotype distribution, genetic diversity, and evolutionary patterns of DENV in this region. The study also explores the epidemiological implications of these molecular characteristics, providing valuable insights into local transmission dynamics and public health challenges. The findings highlight the critical role of continuous molecular surveillance in informing effective dengue control strategies.

Abstract 14 | PDF Downloads 1

References

1. Bhatt, S., Gething, P.W., Brady, O.J., Messina, J.P., Farlow, A.W., Moyes, C.L., Drake, J.M., et al. (2013). "The global distribution and burden of dengue." Nature, 496(7446), 504-507.
2. Guzman, M.G., & Harris, E. (2015). "Dengue." The Lancet, 385(9966), 453-465.
3. Halstead, S.B. (2007). "Dengue." The Lancet, 370(9599), 1644-1652.
4. Gubler, D.J. (2012). "The economic burden of dengue." American Journal of Tropical Medicine and Hygiene, 86(5), 743-744.
5. Shepard, D.S., Undurraga, E.A., & Halasa, Y.A. (2013). "Economic and disease burden of dengue in Southeast Asia." PLoS Neglected Tropical Diseases, 7(2), e2055.
6. Rico-Hesse, R. (2010). "Molecular evolution and distribution of dengue viruses type 1 and 2 in nature." Virology, 174(2), 479-493.
7. Dejnirattisai, W., Supasa, P., Wongwiwat, W., et al. (2010). "Antibody-dependent enhancement mediates the cross-serotype reactivity of the human immune response to dengue infection." Nature Immunology, 11(9), 927-933.
8. Holmes, E.C., Burch, S.S., & Zhang, L. (2002). "The evolution of dengue virus: evidence for intra-host genetic recombination in the envelope gene." Journal of Virology, 76(7), 3771-3780.
9. Whitehorn, J., & Simmons, C.P. (2011). "The pathogenesis of dengue." Vaccine, 29(42), 7221-7228.
10. Messina, J.P., Brady, O.J., Scott, T.W., Zou, C., Pigott, D.M., Duda, K.A., et al. (2014). "Global spread of dengue virus types: mapping the 70-year history." Trends in Microbiology, 22(3), 138-146.
11. Murray, N.E.A., Quam, M.B., & Wilder-Smith, A. (2013). "Epidemiology of dengue: past, present, and future prospects." Clinical Epidemiology, 5, 299-309.
12. Weaver, S.C., & Vasilakis, N. (2009). "Molecular evolution of dengue viruses: contributions of phylogenetics to understanding the history and epidemiology of the preeminent arboviral disease." Infectious Genetics and Evolution, 9(4), 523-540.
13. Capeding, M.R., Tran, N.H., Hadinegoro, S.R., et al. (2014). "Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial." The Lancet, 384(9951), 1358-1365.
14. Sridhar, S., Luedtke, A., Langevin, E., et al. (2018). "Effect of dengue serostatus on dengue vaccine safety and efficacy." New England Journal of Medicine, 379(4), 327-340.
15. Screaton, G., Mongkolsapaya, J., Yacoub, S., & Roberts, C. (2015). "New insights into the immunopathology and control of dengue virus infection." Nature Reviews Immunology, 15(12), 745-759.
16. Wilder-Smith, A., Ooi, E.E., Vasudevan, S.G., & Gubler, D.J. (2010). "Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development." Current Infectious Disease Reports, 12(3), 157-164.